Back to Search
JAMES ECONOMOU, MD
MD
Surgical Oncology Physician
NPI: 1245244664IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgical Oncology PhysicianPrimary
Surgery — Surgical Oncology
Code: 2086X0206X
C40192(CA)
CMS Specialties
PrimarySURGICAL ONCOLOGY
Education
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Class of 1980
Research & Publications (20)
Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade.
PMID 19118070·Clin Cancer Res·2009
8-other
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma.
PMID 18452610·J Transl Med·2008
3-trial
CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model.
PMID 18606658·J Immunol·2008
8-other
Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma.
PMID 18317358·J Immunother·2008
3-trial
Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer.
PMID 17522860·Cancer Immunol Immunother·2007
8-other
Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanoma.
PMID 17434437·Am J Ophthalmol·2007
3-trial
Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade).
PMID 16585569·J Immunol·2006
7-preclinical
NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain.
PMID 17142742·J Immunol·2006
7-preclinical
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
PMID 16675576·Clin Cancer Res·2006
3-trial
Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays.
PMID 16397031·Clin Cancer Res·2006
4-observational
Broad antitumor protection by dendritic cells administered to CD8alpha knock out mice.
PMID 16133107·Cancer Immunol Immunother·2006
7-preclinical
Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells.
PMID 15775996·Cancer Gene Ther·2005
7-preclinical
Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells.
PMID 15554925·Immunology·2004
8-other
Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma.
PMID 15296814·Control Clin Trials·2004
8-other
Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells.
PMID 15294960·J Immunol·2004
7-preclinical
Enhanced tumor responses to dendritic cells in the absence of CD8-positive cells.
PMID 15067052·J Immunol·2004
7-preclinical
Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro.
PMID 14500402·Cancer Res·2003
8-other
T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.
PMID 14676113·Clin Cancer Res·2003
3-trial
Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors.
PMID 14551273·J Vasc Interv Radiol·2003
8-other
Current developments in cancer vaccines and cellular immunotherapy.
PMID 12805342·J Clin Oncol·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 MEDICAL PLAZA, #120
LOS ANGELES, CA 90095 - Phone
- (310) 794-1646
Quick Facts
- NPI
- 1245244664
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile